Walgreens to close 600 stores, spend $750M to rebrand Rite Aids

Walgreens plans to close about 600 stores over an 18-month period beginning next year, according to the Chicago Sun-Times.

Advertisement

The Deerfield, Ill.-based company made the announcement in the wake of its purchase of the Rite Aid drugstore chain. Under an agreement that received regulatory approval in September, Walgreens is buying 1,932 Rite Aid stores, three distribution centers and inventory for $4.38 billion.  

The deal replaced the companies’ earlier $6.8 billion purchase agreement, which Walgreens walked away from in June. On an earnings call Wednesday, Walgreens said termination fees and costs related to its pursuit of Rite Aid caused earnings to fall to $802 million in the fourth quarter of fiscal year 2017, down from $1.03 billion in the same period the year prior, according to the report.

Walgreens plans to close stores, mostly Rite Aids, that are within 1 mile of another Rite Aid or Walgreens. Walgreens will spend $750 million over the next three years to rebrand the remaining Rite Aid stores, according to Forbes.

More articles on leadership and management:

Louisville healthcare leaders join together to form CEO council
Mass General, Brigham & Women’s presidents object to Massachusetts price variation bill
How to avoid Medicaid disenrollment nightmares

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.